Pharmacogenetically Driven Treatments for Alcoholism: Are We There Yet?

Author： Arias Albert J.   Sewell R. Andrew  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.6, 2012-06, pp. : 461-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailoring Therapy for Locally Advanced Breast Cancer Using Molecular Profiles: Are We There Yet?

By Fosker Christopher  

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 1947-1955

Adis International

Access to resources Recommend Favorite

Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet?

By Staatz Christine E.   Tett Susan E.  

Clinical Pharmacokinetics, Vol. 50, Iss. 12, 2011-12 ,pp. : 759-772

Adis International

Access to resources Recommend Favorite

What Place Does Naltrexone Have in the Treatment of Alcoholism?

By Rohsenow D.J.  

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 547-560

Adis International

Access to resources Recommend Favorite

New treatments for Tourette's syndrome?

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

New treatments for rotavirus infection?

By  

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite